Search

everythinglearnresearchcommunity

for

Search:↓

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Significant facial gender transformation requires surgery, not nonsurgical methods.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Hair significantly shapes body identity and social interactions, influencing how we perceive and relate to our bodies.

The healthcare for transgender veterans could be better with a more unified team approach.